Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacopo Venturini

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cancers|June 12, 2026
Circulating Tumor DNA as Emerging Predictive and Prognostic Biomarker in Prostate CancerBicky Thapa, Jacopo Venturini, Atish D Choudhury, et al.
Experimental Hematology & Oncology|May 19, 2025
Developments in nanotechnology approaches for the treatment of solid tumorsJacopo Venturini, Abhijit Chakraborty, Mehmet A Baysal, et al.
Cancers|December 23, 2022
Lung Cancer Immunotherapy: Beyond Common Immune Checkpoints InhibitorsMartina Catalano, Sonia Shabani, Jacopo Venturini, et al.
Critical Reviews in Oncology/Hematology|September 20, 2024
The emerging HER2 landscape in colorectal cancer: the key to unveil the future treatment algorithm?Jacopo Venturini, Giulia Massaro, Daniele Lavacchi, et al.
Critical Reviews in Oncology/Hematology|April 28, 2025
Beneath the surface of colorectal cancer: Unmasking the evolving nature of (Neo)RASGiulia Massaro, Jacopo Venturini, Daniele Rossini, et al.
International Journal of Molecular Sciences|March 29, 2023
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal CancerDaniele Lavacchi, Giandomenico Roviello, Alessia Guidolin, et al.
Critical Reviews in Oncology/Hematology|April 12, 2026
Therapeutic sequencing and role of cabozantinib after immunotherapy in metastatic renal cell carcinomaMartina Catalano, Jacopo Venturini, Ismaela Anna Vascotto, et al.
Frontiers in Oncology|December 16, 2022
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancerDaniele Lavacchi, Sara Fancelli, Giandomenico Roviello, et al.
Frontiers in Oncology|May 13, 2026
Case Report: Niraparib-abiraterone in HRR-mutated metastatic castration-resistant prostate cancer: clinical insights from five casesIsmaela Anna Vascotto, Martina Catalano, Jacopo Venturini, et al.
NPJ Precision Oncology|May 25, 2026
Circulating cell-free methylated DNA immunoprecipitation sequencing (cfMeDIP-seq) in oncology: from technological advances to clinical applicationsEdoardo Francini, Sara Bleve, Giuseppe Nicolo Fanelli, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cancers|June 12, 2026
Circulating Tumor DNA as Emerging Predictive and Prognostic Biomarker in Prostate CancerBicky Thapa, Jacopo Venturini, Atish D Choudhury, et al.
Experimental Hematology & Oncology|May 19, 2025
Developments in nanotechnology approaches for the treatment of solid tumorsJacopo Venturini, Abhijit Chakraborty, Mehmet A Baysal, et al.
Cancers|December 23, 2022
Lung Cancer Immunotherapy: Beyond Common Immune Checkpoints InhibitorsMartina Catalano, Sonia Shabani, Jacopo Venturini, et al.
Critical Reviews in Oncology/Hematology|September 20, 2024
The emerging HER2 landscape in colorectal cancer: the key to unveil the future treatment algorithm?Jacopo Venturini, Giulia Massaro, Daniele Lavacchi, et al.
Critical Reviews in Oncology/Hematology|April 28, 2025
Beneath the surface of colorectal cancer: Unmasking the evolving nature of (Neo)RASGiulia Massaro, Jacopo Venturini, Daniele Rossini, et al.
International Journal of Molecular Sciences|March 29, 2023
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal CancerDaniele Lavacchi, Giandomenico Roviello, Alessia Guidolin, et al.
Critical Reviews in Oncology/Hematology|April 12, 2026
Therapeutic sequencing and role of cabozantinib after immunotherapy in metastatic renal cell carcinomaMartina Catalano, Jacopo Venturini, Ismaela Anna Vascotto, et al.
Frontiers in Oncology|December 16, 2022
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancerDaniele Lavacchi, Sara Fancelli, Giandomenico Roviello, et al.
Frontiers in Oncology|May 13, 2026
Case Report: Niraparib-abiraterone in HRR-mutated metastatic castration-resistant prostate cancer: clinical insights from five casesIsmaela Anna Vascotto, Martina Catalano, Jacopo Venturini, et al.
NPJ Precision Oncology|May 25, 2026
Circulating cell-free methylated DNA immunoprecipitation sequencing (cfMeDIP-seq) in oncology: from technological advances to clinical applicationsEdoardo Francini, Sara Bleve, Giuseppe Nicolo Fanelli, et al.
Pageof 2